Skip to main content
Premium Trial:

Request an Annual Quote

Ross Perot Gives MD Anderson $20M

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Ross Perot has donated $20 million to the University of Texas MD Anderson Cancer Center to develop new cancer therapies, the center announced yesterday.

The funds will be divided equally between MD Anderson's Institute for Personalized Cancer Therapy and a Center for Targeted Therapy.

IPCT leverages discoveries made by its researchers to determine specific genetic and molecular abnormalities in a patient's cancer so that appropriate therapies can be prescribed. CTT is one of seven centers in the Red and Charline McCombs Institute for the Early Detection and Treatment of Cancer at MD Anderson and is focused on coordinating all stages of the new-drug discovery and development process in order to accelerate new and less toxic drugs to the clinic from the research lab.

According to John Mendelsohn, president of MD Anderson, the donation from Perot will accelerate research into genetic blueprints, the identification of biomarkers, the development of cancer drugs, and the testing of new drugs in clinical trials.

"These funds will enable our clinicians and researchers to advance the translation of science into new and improved cancer treatments," Mendelsohn said in a statement.

Perot, who ran for President in 1992 and 1996, is the founder of Electronic Data Systems and Perot Systems.

The Scan

Cell Atlas of Human Lung Development Gives View of Developing Airway

Researchers have generated a cell atlas of human lung development, which they report in Cell.

Study Finds Costs of Genome Sequencing May Limit Utility in Routine Care

Researchers report in the European Journal of Human Genetics that genome sequencing for rare disease diagnoses currently has similar benefits as less expensive exome analysis.

Study Suggests Nursing Mother's Diet Can Impact Offspring's Gut Microbiome

A new Cell Host and Microbe paper finds that mice whose mothers were fed a low-fiber diet during nursing experience lasting microbiota dysbiosis and increased obesity.

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.